Trials / Recruiting
RecruitingNCT04754022
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Younger Patients Undergoing Cardiac Surgery
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,440 (estimated)
- Sponsor
- Unity Health Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
TRICS-IV is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in moderate to high risk patients who are 65 years of age or younger undergoing cardiac surgery on cardiopulmonary bypass, using a superiority trial design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Restrictive Transfusion Strategy | Patients will receive a RBC transfusion if their Hb concentration is \<75 g/L (\<7.5 g/dL; \<4.7mmol/L) intraoperatively and/or postoperatively. |
| OTHER | Liberal transfusion strategy | Patients will receive a RBC transfusion if their Hb concentration is \<95 g/L (\<9.5 g/dL; \<5.9mmol/L) intraoperatively, or postoperatively in the ICU; and/or \<85 g/L (\< 8.5 g/dL; \<5.3mmol/L) on the ward. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2025-12-01
- Completion
- 2026-06-01
- First posted
- 2021-02-15
- Last updated
- 2024-11-21
Locations
54 sites across 16 countries: United States, Australia, Canada, Colombia, Egypt, Greece, India, Namibia, Nepal, Romania, Russia, Singapore, South Africa, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT04754022. Inclusion in this directory is not an endorsement.